• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCoronavirus

Coronavirus

Page 92 of 100
Global stocks rebound as investors shrug off the Omicron risk. Crypto pain continues
Newsletters
Global stocks rebound as investors shrug off the Omicron risk. Crypto pain continues
By Bernhard WarnerDecember 6, 2021
Evidence mounts that Omicron is more infectious, less severe than Delta—but Fauci, other experts warn against premature optimism
Health
Evidence mounts that Omicron is more infectious, less severe than Delta—but Fauci, other experts warn against premature optimism
By Grady McGregorDecember 6, 2021
The soft stuff is the hard stuff: Leaders must show vulnerability in uncertain times
Commentary
The soft stuff is the hard stuff: Leaders must show vulnerability in uncertain times
By Leena NairDecember 5, 2021
What happens when the vaccines stop working
Health
What happens when the vaccines stop working
By Megan LeonhardtDecember 4, 2021
Marijuana sales
Finance
Cannabis taxes may generate $12 billion for U.S. states by 2030, according to Barclays strategists
By Martin Z. Braun and BloombergDecember 3, 2021
Anime convention in New York City
Health
A crowd of 53,000 at a New York City anime convention spark Omicron fears
By Elaine Chen and BloombergDecember 3, 2021
Barista working at a cafe in NYC
Finance
November jobs report disappoints as the U.S. adds just 210,000 jobs
By Christopher Rugaber and The Associated PressDecember 3, 2021
Covid-19 Testing at Testaro Sites as South Africa's Omicron Cases Rise
Health
Children, contagiousness, severity: What we know (and don’t know) about the Omicron COVID variant so far
By Sophie MellorDecember 3, 2021
How tech companies are disrupting everything from brain surgery to emergency training to bank payments
Newsletters
How tech companies are disrupting everything from brain surgery to emergency training to bank payments
By Katherine Dunn and Alan MurrayDecember 3, 2021
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
Health
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
By Suzi Ring, Irina Anghel and BloombergDecember 3, 2021
Ahead of the bell today, economists expect that employers made an additional 550,000 hires last month.
Newsletters
Stocks and crypto flatline ahead of today’s decisive jobs report
By Bernhard WarnerDecember 3, 2021
Omicron emphasizes the importance of genomic surveillance
Newsletters
Omicron emphasizes the importance of genomic surveillance
By Yasmin TayagDecember 2, 2021
Photo of a health care worker holding a COVID test swab.
Health
Singapore doctor: Omicron will likely ‘dominate and overwhelm’ the world by spring
By Chris MorrisDecember 2, 2021
South Africa is offering people a share of $126,000 if they get the COVID-19 vaccine
South Africa is offering people a share of $126,000 if they get the COVID-19 vaccine
By Paul Burkhardt and BloombergDecember 2, 2021
Germany will make COVID vaccinations mandatory if Angela Merkel gets her way
Health
Germany will make COVID vaccinations mandatory if Angela Merkel gets her way
By Christiaan HetznerDecember 2, 2021
1...
  • 90
  • 91
  • 92
  • 93
  • 94
...100
Most Popular
Success
Steve and Connie Ballmer are splitting their $8 billion philanthropy into three so the people closest to the work can decide how the money is spentplaceholder alt text
By Sydney LakeAugust 11, 2026
Economy
U.S. Treasury is paying $3 billion a day in interest on national debt, says the CBO—having spent $10 billion to prop up the currency of its top lenderplaceholder alt text
By Eleanor PringleAugust 11, 2026
North America
Google cofounder Sergey Brin has now spent $100 million to fight California’s proposed billionaire tax—he could owe $13 billion if he losesplaceholder alt text
By Sasha RogelbergAugust 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.